Position in ZYBT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,410
-$2,103 QoQ
Shares Held
7,992
-0.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 8 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYBT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. ZYBT ranks #70 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in ZYBT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,410 | 7,992 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,513 | 8,036 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $10,481 | 9,115 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $11,341 | 4,329 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $922,435 | 154,512 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,934 | 1,289 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||